Use of human iPSC-CMs in nonclinical regulatory studies for cardiac safety assessment

X Yang, AJS Ribeiro, L Pang… - Toxicological …, 2022‏ - academic.oup.com
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide a
human-relevant platform for cardiac function assessment. Alternative assays using hiPSC …

Current status of cardiac regenerative therapy using induced pluripotent stem cells

T Sugiura, DC Shahannaz, BE Ferrell - International Journal of Molecular …, 2024‏ - mdpi.com
Heart failure (HF) is a life-threatening disorder and is treated by drug therapies and surgical
interventions such as heart transplantation and left ventricular assist device (LVAD) …

Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin

L Pang, C Cai, P Aggarwal, D Wang… - Toxicological …, 2024‏ - academic.oup.com
Many oncology drugs have been found to induce cardiotoxicity in a subset of patients, which
significantly limits their clinical use and impedes the benefit of lifesaving anticancer …

[HTML][HTML] Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes

K Kistamás, A Müller, S Muenthaisong… - Journal of Molecular …, 2023‏ - Elsevier
Cardiovascular diseases are the leading cause of death worldwide. Several strategies–
small molecules, gene therapy, surgeries, cardiac rehabilitation–have been developed to …